Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W, Porter D. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet. 2004;364(9430):263–9.
Article
Google Scholar
Kavanaugh A, van Vollenhoven RF, Fleischmann R, Emery P, Sainsbury I, Florentinus S, Chen S, Guerette B, Kupper H, Smolen JS. Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis. Ann Rheum Dis. 2018;77(2):289–92.
Article
CAS
Google Scholar
Lau CS, Chia F, Dans L, Harrison A, Hsieh TY, Jain R, Jung SM, Kishimoto M, Kumar A, Leong KP, et al. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis. Int J Rheum Dis. 2019;22(3):357–75.
Article
Google Scholar
Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2016;68(1):1–26.
Article
Google Scholar
Smolen JS, Landewe RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–99.
Article
CAS
Google Scholar
Grabner M, Boytsov NN, Huang Q, Zhang X, Yan T, Curtis JR. Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis. Arthritis Res Ther. 2017;19(1):92.
Article
Google Scholar
Navarro F, Martinez-Sesmero JM, Balsa A, Peral C, Montoro M, Valderrama M, Gomez S, de Andres-Nogales F, Casado MA, Oyaguez I. Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain. Clin Rheumatol. 2020;39(10):2919–30.
Article
CAS
Google Scholar
Lequerre T, Rottenberg P, Derambure C, Cosette P, Vittecoq O. Predictors of treatment response in rheumatoid arthritis. Joint Bone Spine. 2019;86(2):151–8.
Article
Google Scholar
Cuppen BV, Welsing PM, Sprengers JJ, Bijlsma JW, Marijnissen AC, van Laar JM, Lafeber FP, Nair SC. Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability. Rheumatology (Oxford). 2016;55(5):826–39.
Article
CAS
Google Scholar
Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C. Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken). 2010;62(8):1128–43.
Article
Google Scholar
Wijbrandts CA, Tak PP. Prediction of response to targeted treatment in rheumatoid arthritis. Mayo Clin Proc. 2017;92(7):1129–43.
Article
CAS
Google Scholar
Barnabe C, Sun Y, Boire G, Hitchon CA, Haraoui B, Thorne JC, Tin D, van der Heijde D, Curtis JR, Jamal S, et al. Heterogeneous disease trajectories explain variable radiographic, function and quality of life outcomes in the Canadian Early Arthritis Cohort (CATCH). PLoS ONE. 2015;10(8):e0135327.
Article
Google Scholar
Leu Agelii M, Andersson M, Jones BL, Sjowall C, Kastbom A, Hafstrom I, Forslind K, Gjertsson I. Disease activity trajectories in rheumatoid arthritis: a tool for prediction of outcome. Scand J Rheumatol. 2021;50(1):1–10.
Article
CAS
Google Scholar
Norton S, Sacker A, Dixey J, Done J, Williams P, Young A, Early Rheumatoid Arthritis S. Trajectories of functional limitation in early rheumatoid arthritis and their association with mortality. Rheumatology (Oxford). 2013;52(11):2016–24.
Article
Google Scholar
Siemons L, Ten Klooster PM, Vonkeman HE, Glas CA, Van de Laar M. Distinct trajectories of disease activity over the first year in early rheumatoid arthritis patients following a treat-to-target strategy. Arthritis Care Res (Hoboken). 2014;66(4):625–30.
Article
Google Scholar
Wabe N, Wojciechowski J, Wechalekar MD, Cleland LG, McWilliams L, Lee A, Proudman S, Wiese MD. Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy. Int J Rheum Dis. 2017;20(10):1447–56.
Article
CAS
Google Scholar
Bykerk VP, Lee EB, van Vollenhoven R, Gruben DC, Fallon L, Woolcott JC, Keystone E. Identification of distinct disease activity trajectories in methotrexate-naive patients with rheumatoid arthritis receiving tofacitinib over twenty-four months. Arthritis Care Res (Hoboken). 2022;74(1):131–41.
Article
CAS
Google Scholar
Consortium R-M. Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study. Ther Adv Musculoskelet Dis. 2021;13:1759720X211043977.
Google Scholar
Norton S, Fu B, Scott DL, Deighton C, Symmons DP, Wailoo AJ, Tosh J, Lunt M, Davies R, Young A, et al. Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts. Semin Arthritis Rheum. 2014;44(2):131–44.
Article
Google Scholar
Pan Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, Symmons DPM, Lunt M, Young A, Consortium B-RCC, Hyrich KL, Verstappen SMM. Not all moderate disease is the same - identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity. PLoS One. 2019;14(5):e0215999.
Article
CAS
Google Scholar
Shin K, Choi SJ, Kwak S-K, Park Y-B, Sung Y-K, Choi C-B, Jeon CH, Lee J, Nam EJ, Kim S-K, et al. AB1066 Korean Biologics Registry of Patients with Systemic Rheumatic Disease (KOBIO): a nationwide registry to assess adverse events associated with biologic treatment in Korea. Ann Rheum Dis. 2014;73:1153–4.
Article
Google Scholar
Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38.
Article
Google Scholar
Chen T, Guestrin C. XGBoost a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco: Association for Computing Machinery; 2016. p. 785–94.
Chapter
Google Scholar
Lundberg SM, Lee S-I. A unified approach to interpreting model predictions: Proceedings of the 31st International Conference on Neural Information Processing Systems December 2017. Adv Neural Inform Process Syst. 2017;30:4768–77.
Google Scholar
Isaacs JD, Ferraccioli G. The need for personalised medicine for rheumatoid arthritis. Ann Rheum Dis. 2011;70(1):4.
Article
CAS
Google Scholar
Tak PP. A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm. Rheumatology (Oxford). 2012;51(4):600–9.
Article
CAS
Google Scholar
Koo BS, Eun S, Shin K, Yoon H, Hong C, Kim D-H, Hong S, Kim Y-G, Lee C-K, Yoo B, et al. Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics. Arthritis Res Ther. 2021;23(1):178.
Article
CAS
Google Scholar
Chaudhari K, Rizvi S, Syed BA. Rheumatoid arthritis: current and future trends. Nat Rev Drug Discovery. 2016;15(5):305–6.
Article
CAS
Google Scholar
Shams S, Martinez JM, Dawson JRD, Flores J, Gabriel M, Garcia G, Guevara A, Murray K, Pacifici N, Vargas MV, et al. The therapeutic landscape of rheumatoid arthritis: current state and future directions. Front Pharmacol. 2021;12(1233):680043.
Article
CAS
Google Scholar
Moller B, Scherer A, Forger F, Villiger PM, Finckh A, Swiss Clinical Quality Management Program for Rheumatic D. Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study. Ann Rheum Dis. 2014;73(4):691–6.
Article
Google Scholar
Wilson A, Yu HT, Goodnough LT, Nissenson AR. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004;116(Suppl 7A):50S-57S.
Article
Google Scholar
Park YJ, Cho CS, Emery P, Kim WU. LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study. PLoS ONE. 2013;8(7):e68975.
Article
CAS
Google Scholar